Galactooligosaccharides - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

According to Mordor Intelligence, the galactooligosaccharides market, valued at USD 1.05 billion in 2025, is projected to grow to USD 1.12 billion in 2026 and reach USD 1.54 billion by 2031, with a CAGR of 6.63% from 2026 to 2031.

This report is Segmented by Form (Syrup/Liquid, Powder), Application (Infant Formula, Functional Foods and Beverages, Dietary Supplements, Pharmaceuticals, Animal Feed, Cosmetics), and Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Galactooligosaccharides Market Trends and Insights

Rising Consumer Awareness About Gut Health and Prebiotic Benefits

The galactooligosaccharides market is gaining from stronger public familiarity with gut microbiome science and from the fact that GOS has an established clinical profile rather than a newly emerging one. The Global Prebiotic Association states that GOS selectively ferments in the lower gastrointestinal tract and supports the production of short-chain fatty acids and bifidobacteria, which keeps the ingredient closely linked to well-understood digestive health benefits. In the galactooligosaccharides market, this matters because brand owners usually prefer ingredients that already fit existing consumer understanding and formulation language. The same pattern also helps GOS travel across infant, adult, and therapeutic products without requiring a new education cycle for each format. That broad recognition gives the galactooligosaccharides market a more stable demand base than many newer prebiotic candidates that still need to prove both efficacy and commercial fit.

Expansion of Functional Food and Beverage Markets

The galactooligosaccharides market is also supported by steady expansion in functional food and beverage development, where product teams want ingredients that combine digestive relevance with workable formulation behavior. A 2026 review in 3 Biotech reported that GOS showed consistent beneficial effects on gut microbiota across in vitro, animal, and clinical work in functional food and therapeutic settings. In the galactooligosaccharides market, that body of evidence gives manufacturers a more practical basis for inclusion in beverages, fortified foods, and daily wellness products. The commercial effect is stronger in categories where repeat use depends on both consumer acceptance and scientific support. This keeps functional food and beverage demand relevant to long-term volume growth even when infant nutrition remains the largest application.

Limited Raw Material Availability and Supply Chain Vulnerability

The galactooligosaccharides market remains exposed to lactose availability because lactose is still the main feedstock for enzymatic GOS production. This creates a supply risk that is difficult for producers to control on their own because major lactose output is concentrated in a relatively small number of dairy processing regions. The issue is especially important in the galactooligosaccharides market in Asia, where capacity growth can increase reliance on imported lactose and add freight cost and lead-time pressure. Shandong Bailong Chuangyuan's December 2025 strategic agreement with Golden Corn shows how producers are trying to strengthen raw material access, even though that does not fully solve structural dependence on dairy-linked feedstock. If supply disruption affects key lactose-producing regions, the galactooligosaccharides market could face broader cost pressure at the same time that infant nutrition buyers still need secure delivery.

Other drivers and restraints analyzed in the detailed report include:

1. Technological Advancements in Enzymatic Synthesis and Bioprocessing
2. Growing Plant-Based and Vegan Product Portfolios
3. Competition from Alternative Prebiotics

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Powder held 71.2% of galactooligosaccharides market share in 2025, which shows how strongly the format fits existing infant formula, supplement, and dry food manufacturing systems. The galactooligosaccharides market still favors powder because it is ambient-stable, easier to transport through long supply chains, and compatible with common dry blending lines used by food manufacturers. Shandong Bailong Chuangyuan offers 70% and 90% purity powder grades and commissioned a 30,000-ton combined soluble dietary fiber production line in 2024, which supports continued confidence in powder-led output growth. In the galactooligosaccharides industry, that installed base matters because buyers usually value handling consistency as much as headline functionality when they are sourcing ingredients for repeat production.

The galactooligosaccharides market size for the syrup/liquid segment is projected to grow at 7.8% CAGR through 2031, making it the faster-moving form within the category. The galactooligosaccharides market is seeing this shift because beverage fortification, liquid infant formula, and some dairy applications can use direct liquid dosing more easily than powder dispersion. Kerry's enzyme investment is relevant here because higher lactase capacity supports more efficient downstream synthesis and can help improve commercial availability for producers serving liquid applications. The practical benefit is a shorter path from ingredient tank to finished product in applications where solubility and handling speed matter. Within the galactooligosaccharides industry, that makes syrup and liquid formats more attractive in ready-to-drink and other water-based systems where formulation simplicity carries real value.

Complete Report Scope:

• By Form
  • Syrup/Liquid
  • Powder
• By Application
  • Infant Formula
  • Functional Foods and Beverages
  • Dietary Supplements
  • Pharmaceuticals
  • Animal Feed
  • Cosmetics
• By Geography
  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • United Arab Emirates
    • Rest of Middle East and Africa

Geography Analysis

In 2025, Europe dominated the galactooligosaccharides market, accounting for 43.92% of the market size. Europe's stronghold in the galactooligosaccharides market is bolstered by its longstanding acceptance of functional foods and the presence of established suppliers like FrieslandCampina Ingredients in the Netherlands and Clasado Biosciences in the UK. Germany stands out as a significant player, boasting a well-developed food processing base and robust packaged nutrition channels. Meanwhile, North America, a mature player in the galactooligosaccharides arena, still showcases potential for growth, as evidenced by Saputo Dairy UK's GRAS Notice GRN 1216, submitted to the US FDA in August 2024.

Asia-Pacific ranks as the second-largest market for galactooligosaccharides and is a pivotal production hub. The region's robust domestic demand pairs seamlessly with its expansive manufacturing base, particularly in China. Here, suppliers like Quantum Hi-Tech and Shandong Bailong Chuangyuan cater to both local and export markets. Notably, Quantum Hi-Tech claims a commanding 50% share of China's domestic prebiotic market, underscoring the dominance of local producers in this crucial supply region. Japan's longstanding use of GOS in dairy and beverages lends stability to the market, ensuring consistent volume demand.

The Middle East and Africa lead the pack with the fastest growth rate in the galactooligosaccharides market, boasting an 8.01% CAGR projected through 2031. Further emphasizing the region's burgeoning significance, Mordor Intelligence forecasts GOS to expand at a notable 9.98% CAGR within the broader prebiotic ingredients market in the Middle East and Africa. This growth trajectory is largely fueled by high birth rates in GCC nations and Sub-Saharan Africa, sustaining a robust demand for infant formulas. Among African nations, South Africa stands out as the most developed market, driven by the rapid expansion of modern retail and functional food formats.

1. FrieslandCampina Ingredients
2. Yakult Honsha Co., Ltd.
3. Nissin Sugar Co., Ltd.
4. Ingredion Incorporated
5. Kerry Group plc
6. Clasado Biosciences Limited
7. Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.
8. VITALUS NUTRITION INC.
9. Royal FrieslandCampina N.V.
10. Fonterra Co-operative Group Limited
11. Tate and Lyle PLC
12. DuPont de Nemours, Inc.
13. BENEO GmbH
14. Tereos S.A.
15. Hilmar Cheese Company, Inc.
16. First Milk Limited
17. Kowa Europe GmbH
18. Lactose India Limited
19. Samyang Corporation
20. Quantum Hi-Tech Biological Co., Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support